| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/31/2006 | US20060194784 Analogs of clozapine; use with other neuropsychiatric agents; depression, anxiety, bipolar disorder, psychoses secondary to Alzheimer's or Huntington's disease |
| 08/31/2006 | US20060194783 Cgrp receptor antagonists |
| 08/31/2006 | US20060194782 Pharmacologically active imidazo[4,5-c] pyridines |
| 08/31/2006 | US20060194781 Alkyl ether derivatives or salts thereof |
| 08/31/2006 | US20060194780 N-Azacycloalkylcarbonyl-substituted bicyclic piperidines, e.g., N-tert-butyl)-8-{[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidin-3-yl]carbonyl}-3-cyclohexyl-8-azabicyclo[3.2.1]octane-3-carboxamide; useful for treating obesity, diabetes, and sexual dysfunction |
| 08/31/2006 | US20060194779 1H-imidazole derivatives as cannabinoid CB2 receptor modulators |
| 08/31/2006 | US20060194778 Serotonin receptor antagonist; psychological disorders; side effect reduction |
| 08/31/2006 | US20060194777 Compositions and methods using same for treating amyloid-associated diseases |
| 08/31/2006 | US20060194776 Compositions and methods for treating tissue ischemia |
| 08/31/2006 | US20060194775 Estradiol metabolites for the treatment of pulmonary hypertension |
| 08/31/2006 | US20060194774 Increased activity for the treatment of carcinomas and HIV diseases, melanoma, neuroectodermal tumor, sarcoma |
| 08/31/2006 | US20060194773 Tetracyline compounds having target therapeutic activities |
| 08/31/2006 | US20060194772 Triamide-substituted heterobicyclic compounds |
| 08/31/2006 | US20060194771 metals or emissive substances introduced into azobenzene to obtain emissive azobenzene derivatives; aggregate particles; |
| 08/31/2006 | US20060194770 Methods for modulating tumor growth and metastasis |
| 08/31/2006 | US20060194769 Small molecules that reduce fungal growth |
| 08/31/2006 | US20060194768 N-(4-{2-[[3-Bromo-4-(difluoro-phosphono-methyl)-benzyl]-(3 ,4-dichloro-phenyl)-amino]-thiazol-4-yl}-phenyl)-oxalamic acid; antidiabetic, hypotensive agent; ischemia, kidney failure, atherosclerosis, metabolic syndrome, insulin resistance, leptin resistance, obesity, neurodegenerative diseases |
| 08/31/2006 | US20060194767 Novel agents for preventing and treating disorders involving modulation of the RyR receptors |
| 08/31/2006 | US20060194766 Combinations comprising anti-epileptic drugs for the treatment of neurological disorders |
| 08/31/2006 | US20060194765 Methods and compositions using oxidized phospholipids |
| 08/31/2006 | US20060194762 Composition comprising an epothilone and methods for producing a composition comprising an epothilone |
| 08/31/2006 | US20060194761 Olivetol-cyclodextrin complexes and regio-selective process for preparing delta 9-tetrahydrocannabinol |
| 08/31/2006 | US20060194760 Cosmetic preparations |
| 08/31/2006 | US20060194759 Topical compositions and methods for treating pain and inflammation |
| 08/31/2006 | US20060194758 Cross-linking of low and high molecular weight polysaccharides preparation of injectable monophase hydrogels and polysaccharides and dydrogels thus obtained |
| 08/31/2006 | US20060194757 urinary tract incfections; for instillation to bladder |
| 08/31/2006 | US20060194756 Enhancing treatment of HIF-1 mediated disorders with adenosine A3 receptor agonists |
| 08/31/2006 | US20060194755 Compositions and methods for regulating an immune response in a subject |
| 08/31/2006 | US20060194753 Agent for treating leishmania infections |
| 08/31/2006 | US20060194749 9-halo-2-(2'-methyl- beta -D-ribofuanosyl)-2,6-dihydro-2,3,5,6-tetraaza-benzo[cd]azulen-7-one; 9-Amino-2-(2'-methyl- beta -D-ribofuranosyl)-2,6-dihydro-2,3,5,6-tetraaza-benzo[cd]azulen-7-one; for treateing Flaviviridae family of virus infections ( hepatitis C virus) |
| 08/31/2006 | US20060194748 Methods for treating disorders induced by H. pylori infections and pharmaceutical compositions for the same |
| 08/31/2006 | US20060194746 Method and composition to inhibit infections with Helicobacter pylori by intake of procyanidins from type B and C |
| 08/31/2006 | US20060194745 Compounds and methods for inhibiting selectin-mediated function |
| 08/31/2006 | US20060194744 Illudin analogs useful as antitumor agents |
| 08/31/2006 | US20060194743 Method for inhibiting acrylamide formation and use thereof |
| 08/31/2006 | US20060194731 Using tumor antigens to elicit immune response targeted to cancer cells; immunotherapy |
| 08/31/2006 | US20060194723 Novel medication treatment and delivery strategies for Alzheimer's Disease, other disorders with memory impairment, and possible treatment strategies for memory improvement |
| 08/31/2006 | US20060194717 reduced tissue accumulation of the glycopeptide antibiotic, reduced nephrotoxicity and reduced histamine release; side effect reduction |
| 08/31/2006 | US20060194713 Methods for treating delirium using glucocorticoid receptor-specific antagonists |
| 08/31/2006 | US20060194304 Kit comprising sodium chloride, potassium chloride, guanidinium chloride, sodium perchlorate or other chaotropic salt; and a nonionic detergent of Triton, NP40, Tween, or Syperonic, or MOPS buffer; endotoxin-free; purification, centrifuging, chromatography, filtration; gene therapy |
| 08/31/2006 | US20060194293 Rb1 gene induced protein (rb1cc1) and gene |
| 08/31/2006 | US20060194286 Apo-2LI and Apo-3 polypeptides |
| 08/31/2006 | US20060194275 Transporter and ion channels |
| 08/31/2006 | US20060194271 Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex |
| 08/31/2006 | US20060194192 Stabilization of cells and biological specimens for analysis |
| 08/31/2006 | US20060193965 Oilseed processing |
| 08/31/2006 | US20060193962 Preventive or remedy for arthritis |
| 08/31/2006 | US20060193933 Modulating the inflammatory response in target cells by contacting the cells with a compund selected from dihydro-isohumulone, dihydro-isocohumulone, dihydro-isoadhumulone, tetrahydro-isohumulone, tetrahydro-isocohumulone, tetrahydro-isoadhumulone, hexahydro-isohumulone etc. cyclooxygenase inhibitor |
| 08/31/2006 | US20060193931 Nutritional or therapeutic composition containing the compound oleuropeine or one of the derivatives thereof |
| 08/31/2006 | US20060193929 Method for treating or preventing symptoms associated with menopause |
| 08/31/2006 | US20060193927 Combinations of vasoactive agents and their use in the treatment of sexual dysfunctions |
| 08/31/2006 | US20060193926 To treat psychiatric and mood disorders, pain, Parkinson's disease, cognitive dysfunction, epilepsy, circadian rhythm disorders, drug addiction, drug abuse, drug withdrawal, obesity; 2-[1-(3-methoxy-4-pyridin-2-ylphenyl)-1H-pyrrol-3-yl]pyridine; minimal side effects |
| 08/31/2006 | US20060193925 such as pioglitazone, troglitazone, rosiglitazone; plant extracts of Ephedrae Herba, Glycyrrhizae Radix and Gypsum Fibrosum in powder form; reduces body weight gain effect |
| 08/31/2006 | US20060193924 Antimicrobial combination therapy |
| 08/31/2006 | US20060193923 Compositions and methods for increasing muscle mass and strength, improving athletic performance, and/or reducing body fat mass leading to weight loss |
| 08/31/2006 | US20060193920 Nanoparticulate compositions of mitogen-activated protein (map) kinase inhibitors |
| 08/31/2006 | US20060193919 Comprises a metal-containing anti-cancer drug being adsorbed onto or included in oxidized porous carbon nanohorns; novel drug carrier, which is excellent in characteristics of drug adsorption or inclusion and releasing properties |
| 08/31/2006 | US20060193917 potentiating radiotherapy of lung cancer treatment by administering 4(5)-nitro-L-histidine to increase anticarcinogenic agent synergistic effect |
| 08/31/2006 | US20060193916 Formulations of peptides for periodontal and dental treatments |
| 08/31/2006 | US20060193915 Compression coated tablets |
| 08/31/2006 | US20060193913 And salts such as the maleate in particulate form, prepared by wet milling; controlled release compositions |
| 08/31/2006 | US20060193908 Extended release formulations of poorly soluble antibiotics |
| 08/31/2006 | US20060193907 NGNA compositions and methods of use |
| 08/31/2006 | US20060193906 Sugar-modified liposome and products comprising the liposome |
| 08/31/2006 | US20060193905 Direct cellular energy delivery system |
| 08/31/2006 | US20060193904 Encapsulation of drugs in liposomes; encapsulated transition metal ions and encapsulated drugs, where if the drug is soley doxorubicin, the metal ion is not solely manganese, and the liposomes do not comprise an ionophore |
| 08/31/2006 | US20060193903 hydrophobic drug having (a) glycoside like GlcNAc-Gal-, GlcNAc-Gal-Glc-, Fuc-Gal- as sugar moiety (b) phosphatidylcholines (c) stearylamine/oleylamine; composition improves the low solubility of gylcoside; cholestenol/ ceramide/naphthalene-2-methanol -glycoside anticancer drug; improved drug delivery |
| 08/31/2006 | US20060193902 Pharmaceutical compositions containing active agents having a lactone group and transition metal ions |
| 08/31/2006 | US20060193895 Additive for food and beverage, pharmaceutical composition, GLUT4 translocator, and method for translocating GLUT4 |
| 08/31/2006 | US20060193893 Medical devices |
| 08/31/2006 | US20060193887 Medical devices having nanoporous bonding layers |
| 08/31/2006 | US20060193886 Medical devices with nanoporous layers and topcoats |
| 08/31/2006 | US20060193884 terpolymer comprising polyoxyalkylene copolymer, polycaprolactone, with copolymerizable monomers such as glycolide, lactide, p-dioxanone and trimethylene carbonate; surgical sutures; for coating medical equipment |
| 08/31/2006 | US20060193878 Method of Preparing Gas Delivering Perfluorocarbon Emulsions With Non-Fluorinated Surfactants |
| 08/31/2006 | US20060193871 transmission and, or amplification of signal; oral or enteric administering, dissolving, absorption; peptide yy; obesity therapy |
| 08/31/2006 | US20060193855 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells |
| 08/31/2006 | US20060193854 a cancer which expresses epidermal growth factor receptor; blocking ligand activation of a receptor; binding of monoclonal antibody 2C4 to ErbB2; chemotherapeutic agents are 5-fluorouracil leucovorin, levamisole |
| 08/31/2006 | US20060193852 immunotherapy, preferably against B-cell malignancies such as non-Hodgkin lymphoma; single-chain multifunctional polypeptides comprising at least two binding sites specific for the CD19 and CD3 antigen; domains are arranged in the order VLCD19-VHCD19-VHCD3-VLCD3; vector; cell |
| 08/31/2006 | US20060193850 Anti a beta antibody formulation |
| 08/31/2006 | US20060193845 Combination therapy for controlled carbohydrate digestion |
| 08/31/2006 | US20060193835 Treatment of congestive heart failure |
| 08/31/2006 | US20060193834 Antiprotozal composition |
| 08/31/2006 | US20060193826 Methods to mobilize progenitor/stem cells |
| 08/31/2006 | US20060193825 Complex of polypeptide and macromolecular carrier |
| 08/31/2006 | US20060193824 Methods for the treatment of infectious and inflammatory airway diseases |
| 08/31/2006 | US20060193823 Hydrolytically degradable carbamate derivatives of poly (Ethylene Glycol) |
| 08/31/2006 | US20060193822 Antiseptic spermicidal composition and means for its application |
| 08/31/2006 | US20060193818 Compositions containing amines and use thereof |
| 08/31/2006 | US20060193809 Skin care compositions containing a sugar amine cross reference to related application |
| 08/31/2006 | US20060193799 Method of Making Perfluorocarbon Emulsions With Non-Fluorinated Surfactants |
| 08/31/2006 | US20060193798 Aqueous Polymer Dispersion |
| 08/31/2006 | US20060193797 Chroman derivatives as lipoxygenase inhibitors |
| 08/31/2006 | US20060193795 Appetite suppressant mouth spray |
| 08/31/2006 | US20060193790 Promoting whole body health |
| 08/31/2006 | US20060193789 Surfacant, film forming agent, water, gas propellant; plant and animal extracts and oils; may include malathion |
| 08/31/2006 | US20060193785 Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent |
| 08/31/2006 | US20060193784 Scopolamine sublingual spray for the treatment of motion sickness |
| 08/31/2006 | US20060193783 Low dose corticosteroid composition |
| 08/31/2006 | US20060193782 Abuse-proofed dosage form |
| 08/31/2006 | US20060193772 Drugs for treating cancer |